BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9575177)

  • 1. Inositol 1,3,4,5-tetrakisphosphate binding activities of neuronal and non-neuronal synaptotagmins. Identification of conserved amino acid substitutions that abolish inositol 1,3,4,5-tetrakisphosphate binding to synaptotagmins III, V, and X.
    Ibata K; Fukuda M; Mikoshiba K
    J Biol Chem; 1998 May; 273(20):12267-73. PubMed ID: 9575177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional diversity of C2 domains of synaptotagmin family. Mutational analysis of inositol high polyphosphate binding domain.
    Fukuda M; Kojima T; Aruga J; Niinobe M; Mikoshiba K
    J Biol Chem; 1995 Nov; 270(44):26523-7. PubMed ID: 7592870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of synaptotagmin, a Ca2+ and inositol polyphosphate binding protein, in neurotransmitter release and neurite outgrowth.
    Mikoshiba K; Fukuda M; Ibata K; Kabayama H; Mizutani A
    Chem Phys Lipids; 1999 Apr; 98(1-2):59-67. PubMed ID: 10358928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved N-terminal cysteine motif is essential for homo- and heterodimer formation of synaptotagmins III, V, VI, and X.
    Fukuda M; Kanno E; Mikoshiba K
    J Biol Chem; 1999 Oct; 274(44):31421-7. PubMed ID: 10531343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses.
    Mochida S; Fukuda M; Niinobe M; Kobayashi H; Mikoshiba K
    Neuroscience; 1997 Apr; 77(4):937-43. PubMed ID: 9130775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4BP/synaptotagmin II.
    Fukuda M; Aruga J; Niinobe M; Aimoto S; Mikoshiba K
    J Biol Chem; 1994 Nov; 269(46):29206-11. PubMed ID: 7961887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-dependent and -independent hetero-oligomerization in the synaptotagmin family.
    Fukuda M; Mikoshiba K
    J Biochem; 2000 Oct; 128(4):637-45. PubMed ID: 11011146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolutionary pressure to inactivate. A subclass of synaptotagmins with an amino acid substitution that abolishes Ca2+ binding.
    von Poser C; Ichtchenko K; Shao X; Rizo J; Südhof TC
    J Biol Chem; 1997 May; 272(22):14314-9. PubMed ID: 9162066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the calcium-dependent multimerization of synaptotagmin VII mediated by its first and second C2 domains.
    Fukuda M; Mikoshiba K
    J Biol Chem; 2001 Jul; 276(29):27670-6. PubMed ID: 11373279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of Ca2+-dependent protein interactions mediated by the C2A domains of synaptotagmins.
    Sugita S; Südhof TC
    Biochemistry; 2000 Mar; 39(11):2940-9. PubMed ID: 10715114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I.
    Fukuda M
    Biochem J; 2002 Sep; 366(Pt 2):681-7. PubMed ID: 12049610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/function analysis of Ca2+ binding to the C2A domain of synaptotagmin 1.
    Fernández-Chacón R; Shin OH; Königstorfer A; Matos MF; Meyer AC; Garcia J; Gerber SH; Rizo J; Südhof TC; Rosenmund C
    J Neurosci; 2002 Oct; 22(19):8438-46. PubMed ID: 12351718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the C2B domain of synaptotagmin in vesicular release and recycling as determined by specific antibody injection into the squid giant synapse preterminal.
    Fukuda M; Moreira JE; Lewis FM; Sugimori M; Niinobe M; Mikoshiba K; Llinás R
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10708-12. PubMed ID: 7479869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C2B domain of synaptotagmin is a Ca(2+)-sensing module essential for exocytosis.
    Desai RC; Vyas B; Earles CA; Littleton JT; Kowalchyck JA; Martin TF; Chapman ER
    J Cell Biol; 2000 Sep; 150(5):1125-36. PubMed ID: 10974000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of phospholipid binding by the C2A-domain of synaptotagmin I.
    Zhang X; Rizo J; Südhof TC
    Biochemistry; 1998 Sep; 37(36):12395-403. PubMed ID: 9730811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct self-oligomerization activities of synaptotagmin family. Unique calcium-dependent oligomerization properties of synaptotagmin VII.
    Fukuda M; Mikoshiba K
    J Biol Chem; 2000 Sep; 275(36):28180-5. PubMed ID: 10871604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin.
    Chapman ER; Desai RC; Davis AF; Tornehl CK
    J Biol Chem; 1998 Dec; 273(49):32966-72. PubMed ID: 9830048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid composition dependence of Ca2+-dependent phospholipid binding to the C2A domain of synaptotagmin IV.
    Fukuda M; Kojima T; Mikoshiba K
    J Biol Chem; 1996 Apr; 271(14):8430-4. PubMed ID: 8626542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the second C2 domain of synaptotagmin disrupt synaptic transmission at Drosophila neuromuscular junctions.
    Mackler JM; Reist NE
    J Comp Neurol; 2001 Jul; 436(1):4-16. PubMed ID: 11413542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the cytosolic C2A-C2B domains of synaptotagmin III. Implications for Ca(+2)-independent snare complex interaction.
    Sutton RB; Ernst JA; Brunger AT
    J Cell Biol; 1999 Nov; 147(3):589-98. PubMed ID: 10545502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.